Loading insider details...
Beta
Latest Form 4 (Aug 4, 2026): Exercise/Conversion of 31,825,235 GALT shares, $95.48M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 31,825,235 | $95.48M |
| Jan 21, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 13,158 | $40.0K |
| Jan 27, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 32,520 | $40.0K |
| Feb 7, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 23,256 | $40.0K |
| Sep 27, 2023 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 1,466,204 | $7.33M |
| Jan 30, 2023 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 36,036 | $40.0K |
| Feb 8, 2022 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 17,677 | $35.0K |
| Jan 25, 2022 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 1,841,621 | n/a |
| Sep 21, 2021 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 1,157,407 | n/a |
| Apr 19, 2021 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 2,000,000 | n/a |